Embed Size (px)
Chief Editor
A. PÜHLER,Universität Bielefeld,CeBiTec 33594Bielefeld, GermanyEmail: [email protected]
H. BlöckerHelmholtz Centre for Infection Research, Braunschweig, Germany
M.J.T. CarrondoInstituto de Biologia Experimental e Tecnológica (IBET), Oeiras, Portugal
R.L. ChanInstituto de Agrogiotecnología del LitoralSante Fe, Argentina
G.Q. ChenTsinghua University, Beijing, China
M. FusseneggerEidgenössische Technische Hochschule (ETH) Zürich, Basel, Switzerland
A. KondoKobe University, Kobe, Japan
H. SchwabTechnische Universität Graz, Graz, Austria
C. SensenUniversity of Calgary, Calgary, AB, Canada
J-H. SeoSeoul National University (SNU), Seoul, South Korea
F. SriencUniversity of Minnesota, St. Paul, MN, USA
AIMS AND SCOPE
The Journal provides a medium for the rapid publication of both full-length articles and short communications on all aspects of biotechnology. The Journal will accept papers ranging from genetic or molecular biological positions to those covering biochemical, chemical or bioprocess engineering aspects as well as computer application of new software concepts, provided that in each case thematerial is directly relevant to biotechnological systems. Papers presenting information of a multidisciplinary nature that would not be suitable for publication in a journal devoted to a single discipline, are particularly welcome. The following is an outline of the areas covered by the Journal:
Nucleic Acids/Molecular Biology: Novel contributions in the general area of Nucleic Acids/Molecular Biology will be considered. This includes studies for the physical and functional characterization of genomes, studies on the expression of genomic information in cellular and cell-free systems, the development and application of technologies for the detection of single molecules and molecular interactions (molecular recognition), the development and application of strategies towards the identifi cation of biotechnologically interesting new compounds via chemical synthesis (combinatorial strategies in particular), molecular design and evolution, as well as molecular bioinformatics. The development of automated systems for the above mentioned fi elds may be of particular interest.
Physiology/Biochemistry: This section covers biochemical and physiological studies of metabolism and enzymes as relevant to product formation including intermediary metabolism of micro-organisms, tissue culture cells and cell-free systems; bioregulatory investigations at the molecular level including transcription/translation control and growth/product-synthesis relationships; design and engineering of products by molecular strategies with emphasis on protein/enzyme engineering and modifi cation; quality improvement of non-protein products; engineering of cellular modifi cation and transport systems such as post-translational protein modifi cations as well as protein and metabolite secretion; novel (molecular) strategies of screening for new or modifi ed products (e.g. pharmaceuticals, bioactive compounds, enzymes) including applications based on directed evolution and combinatorial strategies.
Biochemical Engineering/Bioprocess Engineering: This section includes studies on transport phenomena, reaction kinetics, design of reactors, downstream operations and software applications as well as research on cellular biology and physiology in biochemical processes employing enzymes, micro-organisms, mammalian cells, plant cells and tissue. Of special interest is the rational manipulation of reactions through metabolic engineering techniques, the design of specifi c biocatalysts, or specifi c reactor operations that lead to biomaterials with unique properties. The use of a quantitative framework for the description of the processes to enhance the understanding of the experimental data is encouraged.
Industrial Processes/New Products: Articles describing the design, simulation, experimental testing/validation and economic evaluation of novel processes using biotechnological approaches, their products or devices constitute the area of interest of this section. Papers dealing with biologically based process integration with clear rational approaches to design and evaluation are particularly welcome; similarly, products and devices should be interpreted in the broadest sense and use or integrate different technologies, as long as the core technology and/or the design rationale are biologically or biochemically based.
Medical Biotechnology: Manuscripts submitted for the Medical Biotechnology section are expected to put current progress in life ciences and life technologies into therapeutic perspective. Medical Biotechnology is covering pioneering activities related to molecular diagnostics and drug discovery, genetic and protein-based vaccines, gene therapy, tissue engineering, stem cell biology, cancer markersand therapeutics, drugs and drug targets for treatment of human pathologies, metabolic and infectious diseases and molecular characterization of viral, bacterial and parasitic infections.
Agro- and Food Biotechnology: Manuscripts in this section should focus on current or novel crop plants and domesticated animal speciesor contribute substantially to the improvement of their performance. Conservation and utilisation of biodiversity, development of toolscontributing to marker assisted breeding, improved transformation approaches, introduction of novel traits and contributions to unravel host-pathogen interactions to improve pest control are of particular interest. Issues related to IPRs, nutritional aspects concerned by improved quantifi cation assays and control measures for desirable or undesirable compounds and issues related to food safety should also be addressed in this section.
Genomics and Bioinformatics: This section accepts articles, which are focused on the application of Genomics and Bioinformatics in Biotechnology research. This includes the characterization of genomes of organisms, which are relevant to Biotechnology by DNA sequencing and the use of Transcriptomics, Proteomics and Metabolomics applications. In addition, Bioinformatic tool development and analyses relevant to Biotechnology are also encouraged. Special emphasis is given to the applicability of the results.
Handling Editors
Submission of manuscripts: Submission of a paper to the Journal of Biotechnology implies: (1) that it is not being submitted for publication elsewhere; (2) the transfer of the copyright from the author to the Publisher.
Authors are requested to submit their manuscripts electronically, by using the EES online submission tool at http://ees.elsevier.com/jbiotec/. After registration, authors will be asked to upload their article, an extra copy of the abstract, and associated artwork. The submission tool will generate a PDFfi le to be used for the reviewing process. The submission tool generates an automatic reply and a manuscript number will be generated for future correspondence.
Language (Usage and Editing services): Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientifi c English may wish to use the English Language Editing service available from Elsevier’s WebShop http://webshop.elsevier.com/languageediting/ or visit our customer support site http://support.elsevier.com for more information.
Authors should further note that fi nal acceptance resides with the Chief Editor, Professor A. Pühler.
Publication information: Journal of Biotechnology (ISSN 0168-1656). For 2013, volumes 163–168 (24 issues) are scheduled for publication. Subscription prices are available upon request from the Publisher or from the Elsevier Customer Service Department nearest you or from this journal’s website (http://www.elsevier.com/locate/jbiotec). Further information is available on this journal and other Elsevier products through Elsevier’s website (http://www.elsevier.com). Subscriptions are accepted on a prepaid basis only and are entered on a calendar year basis. Issues are sent by standard mail (surface within Europe, air delivery outside Europe). Priority rates are available upon request. Claims for missing issues should be made within six months of the date of dispatch.
Orders, claims, and journal enquiries: please contact the Elsevier Customer Service Department nearest you:
St. Louis: Elsevier Customer Service Department, 3251 Riverport Lane, Maryland Heights, MO 63043, USA; phone: (877) 8397126 [toll free within the USA];(+1) (314) 4478878 [outside the USA]; fax: (+1) (314) 4478077; e-mail: [email protected]
Oxford: Elsevier Customer Service Department, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK; phone: (+44) (1865) 843434; fax: (+44) (1865) 843970; e-mail: [email protected]
Tokyo: Elsevier Customer Service Department, 4F Higashi-Azabu, 1-Chome Bldg, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan; phone: (�81) (3) 5561 5037; fax: (�81) (3) 5561 5047; e-mail: [email protected]
Singapore: Elsevier Customer Service Department, 3 Killiney Road, #08-01 Winsland House I, Singapore 239519; phone: (�65) 63490222; fax: (�65) 67331510; e-mail: [email protected]
Author enquiries: For enquiries relating to the submission of articles (including electronic submission) please visit this journal’s homepage at http://www.elsevier.com/locate/jbiotec. For detailed instructions on the preparation of electronic artwork, please visit http://www.elsevier.com/artworkinstructions. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher. You can track accepted articles at http://www.elsevier.com/trackarticle. You can also check our Author FAQs at http://www.elsevier.com/authorFAQ and/or contact Customer Support via http://support.elsevier.com.
Funding body agreements and policies: Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specifi ed as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies
© 2013 Elsevier B.V. All rights reserved.
Advertising information: If you are interested in advertising or other commercial opportunities please e-mail [email protected] and your enquiry will be passed to the correct person who will respond to you within 48 hours.
Journal of Biotechnology has no page charges
For a full and complete Guide for Authors, please go to: http://www.elsevier.com/locate/jbiotec
